Sponsor: MUSC
Sponsor Study ID: 102508
Study Title: Phase II Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
CTO #: 102508
NCT Number: NCT02946996
Phase: II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Prostate
Study Objectives: The overall goal of this Phase II study is to identify safe pharmaceutical agents that can reduce the plasma levels of AGEs in patients with prostate cancer.